Literature DB >> 28566656

Low Heart Rate Variability and Sympathetic Dominance Modifies the Association Between Insulin Resistance and Metabolic Syndrome - The Toon Health Study.

Isao Saito1, Koutatsu Maruyama2, Eri Eguchi3, Tadahiro Kato4, Ryoichi Kawamura5, Yasunori Takata5, Hiroshi Onuma5, Haruhiko Osawa5, Takeshi Tanigawa2.   

Abstract

BACKGROUND: Insulin resistance is strongly associated with metabolic syndrome (MetS), but it is not known how this association is influenced by the autonomic nervous system, which controls insulin secretion.Methods and 
Results: The subjects were 2,016 individuals aged 30-79 years enrolled between 2009 and 2012. MetS was determined using the harmonized MetS definition, which includes waist circumference, blood pressure, triglycerides, high-density lipoprotein cholesterol, and fasting glucose. The homeostasis model assessment index for insulin resistance (HOMA-IR) and Gutt's insulin sensitivity index (ISI) were calculated based on fasting and 2 h-post-load glucose and insulin concentrations in a 75-g oral glucose tolerance test. The 5-min heart rate variability (HRV) was evaluated using time-domain indices of standard deviations of NN intervals (SDNN) and root mean square of successive differences (RMSSD). Power spectral analysis yielded frequency-domain measures for HRV: high-frequency (HF) power, low-frequency (LF) power and LF/HF. Multivariable adjusted logistic models showed that the highest quartiles for SDNN, RMSSD, LF, and HF vs. the lowest quartiles had a significant association with MetS. RMSSD, HF, and LF/HF remained significantly associated with MetS after adjustment for HOMA-IR (or ISI). Additive interactions between the levels of high LF/HF and high HOMA-IR (or low ISI) were significantly positive.
CONCLUSIONS: Sympathovagal imbalance as evidenced by low HF and high LF/HF modified the association of insulin resistance or low insulin sensitivity with MetS.

Entities:  

Keywords:  Epidemiology; Heart rate variability; Insulin sensitivity; Metabolic syndrome

Mesh:

Year:  2017        PMID: 28566656     DOI: 10.1253/circj.CJ-17-0192

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  6 in total

1.  Factors Associated with Reduced Heart Rate Variability in the General Japanese Population: The Iwaki Cross-Sectional Research Study.

Authors:  Masaya Tsubokawa; Miyuki Nishimura; Yoshinori Tamada; Shigeyuki Nakaji
Journal:  Healthcare (Basel)       Date:  2022-04-24

2.  Relationship between sleep-disordered breathing and central systolic blood pressure in a community-based population: the Toon Health Study.

Authors:  Kenta Igami; Koutatsu Maruyama; Kiyohide Tomooka; Ai Ikeda; Yasuharu Tabara; Katsuhiko Kohara; Isao Saito; Takeshi Tanigawa
Journal:  Hypertens Res       Date:  2019-01-30       Impact factor: 3.872

3.  Oxytocin Response Following Playful Mother-Child Interaction in Survivors of the Great East Japan Earthquake.

Authors:  Nobutoshi Nawa; Kazuaki Nakamura; Takeo Fujiwara
Journal:  Front Psychiatry       Date:  2020-06-03       Impact factor: 4.157

Review 4.  Cardiac Autonomic Neuropathy in Obesity, the Metabolic Syndrome and Prediabetes: A Narrative Review.

Authors:  Scott M Williams; Aikaterini Eleftheriadou; Uazman Alam; Daniel J Cuthbertson; John P H Wilding
Journal:  Diabetes Ther       Date:  2019-09-24       Impact factor: 2.945

5.  Relationship between heart rate variability and body mass index: A cross-sectional study of preschool children.

Authors:  Kathryn E Speer; Julian Koenig; Rohan M Telford; Lisa S Olive; Jocelyn K Mara; Stuart Semple; Nenad Naumovski; Richard D Telford; Andrew J McKune
Journal:  Prev Med Rep       Date:  2021-11-16

6.  Salivary Alpha-Amylase Activity in Relation to Cardiometabolic Status in Japanese Adults without History of Cardiovascular Disease.

Authors:  Ai Ikeda; Andrew Steptoe; Eric J Brunner; Koutatsu Maruyama; Kiyohide Tomooka; Tadahiro Kato; Noriko Miyoshi; Shinji Nishioka; Isao Saito; Takeshi Tanigawa
Journal:  J Atheroscler Thromb       Date:  2020-10-10       Impact factor: 4.928

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.